oppalerts.com →
Fertility Clinics

First IVF Planner

Knowledge Graph Entities
Dominant · SE Outbound Links ρ=0.495

AI recommendation signal analysis across 288 domains for the First IVF Planner persona in Fertility Clinics.

288Domains Tracked
First IVF Planner_persona.report
EntityScore
Prelude Fertility
68.9
Pacific Fertility Center Los Angeles (PFCLA)
68.9
Fertility and Sterility
60.3
Mayo Clinic
60.0
Cleveland Clinic
60.0
Want a custom AI visibility audit for Fertility Clinics?

This report tracks how AI models and search engines recommend companies across 100 industries. If you want the same analysis run specifically against your own site and competitors, get in touch.

Get in touch
About This Report

How to use this page

Persona view: this page is scoped to this persona's queries alone.
Use Case

Check your knowledge-graph footprint

Wikidata is the structured knowledge graph behind Wikipedia, search engines, and many AI systems. If the graph does not know a brand, machines have less to anchor an answer on. See which entities carry this segment's topics and brands, and whether its top domains have an entity at all.

How It's Calculated

Where the numbers come from

We scan every Wikidata entity record (labels, descriptions, property values) for this segment's topic phrases and brand hostnames. Entity records are short structured data, so counts run far smaller than article text. Coverage checks which entities claim each domain as an official website.

Overview

What's on this page

Top-entity charts, the full entity table, and a knowledge-graph coverage check for this segment's most LLM-recommended domains.

Segment Totals

Knowledge graph at a glance

How much of the Wikidata knowledge graph touches First IVF Planner. Entity records are short structured data (labels, descriptions, property values), so these counts run far smaller than Wikipedia article text; what matters is which entities show up, not raw volume.

18K
Entities With Topic Matches
4,106
Entities Mentioning Brands
19K
Topic Phrase Matches
4,413
Brand Mentions
Top Domains

Knowledge graph coverage

Whether a Wikidata entity claims each of this segment's most LLM-recommended domains as its official website. A brand without an entity is invisible to systems that navigate the web through the knowledge graph.

6 of 25 top domains for First IVF Planner have a knowledge-graph entity.

DomainKnowledge Graph EntityWikidata ID
ccrmivf.comColorado Center for Reproductive MedicineQ30281877
shadygrovefertility.comShady Grove Fertility CenterQ30281964
rmanetwork.comNot in the knowledge graph-
fertilityiq.comNot in the knowledge graph-
kindbody.comNot in the knowledge graph-
cnyfertility.comNot in the knowledge graph-
resolve.orgNot in the knowledge graph-
springfertility.comNot in the knowledge graph-
sart.orgNot in the knowledge graph-
asrm.orgAmerican Society for Reproductive MedicineQ466817
springerfertility.comNot in the knowledge graph-
extendfertility.comNot in the knowledge graph-
fertilityanswers.comNot in the knowledge graph-
illumefertility.comNot in the knowledge graph-
fertility.wustl.eduNot in the knowledge graph-
nyulangone.orgNYU Langone HealthQ6956114
incintafertility.comNot in the knowledge graph-
bostonivf.comBoston IVFQ30269486
scrcivf.comSouthern California Reproductive CenterQ107518945
ivfmd.comNot in the knowledge graph-
columbiafertility.orgNot in the knowledge graph-
center4reproduction.comNot in the knowledge graph-
nyufertilitycenter.orgNot in the knowledge graph-
fertilitycenter.comNot in the knowledge graph-
advancedfertility.comNot in the knowledge graph-
Wikidata

Top knowledge-graph entities

The entity records where First IVF Planner's brands and topics appear. Brand Mentions is the more reliable single ranking here; broadly used phrases can surface large unrelated entities in the topic view. Blended merges the two on a log scale (brand mentions weighted higher, 0 to 100). Bars and entity names link to the record; entities with no label show their Wikidata ID. The table follows the selected view.


EntityBlendedBrand MentionsTopic Matches
Prelude Fertility68.931
Pacific Fertility Center Los Angeles (PFCLA)68.931
Fertility and Sterility60.313
Mayo Clinic60.040
Cleveland Clinic60.040
Human Resource Management Review60.040
Colorado Center for Reproductive Medicine58.221
Sher Fertility58.221
National Institute for Occupational Safety and Health51.730
Toxicological Sciences51.730
Brain and Language51.730
Virology51.730
Applied Mathematics and Computation51.730
Advances in Virus Research51.730
Advances in Parasitology51.730
Vital and health statistics. Series 21, Data on natality, marriage, and divorce51.730
Vital and health statistics. Series 5, Comparative international vital and health statistics reports51.730
Pacific Fertility Center51.730
Office of Readiness and Response51.730
American Society for Reproductive Medicine43.111
Reproductive Medicine Associates of New York43.111
Reproductive Medicine Associates of New Jersey43.111
Reproductive Medicine Institute43.111
Wave Motion41.020
Ultrasonics Sonochemistry41.020
Clinical Genitourinary Cancer41.020
Journal of Economic Theory41.020
Tetrahedron Letters41.020
BioScience41.020
Nuclear Physics41.020
Trends in Cell Biology41.020
Intelligence41.020
Journal of Operations Management41.020
Annals of Botany41.020
Brachytherapy41.020
Mechanisms of Ageing and Development41.020
Trends in Cardiovascular Medicine41.020
Seminars in Cancer Biology41.020
Journal of Crystal Growth41.020
Field Crops Research41.020
Cardiovascular Pathology41.020
Physica C41.020
Computer Communications41.020
Robotics and Autonomous Systems41.020
Marine Micropaleontology41.020
Comptes Rendus. Biologies41.020
Mathematical Biosciences41.020
International Journal of Medical Informatics41.020
Postharvest Biology and Technology41.020
Nuclear Physics A41.020
Toxicology and Applied Pharmacology41.020
Advances in Agronomy41.020
Cancer Detection and Prevention41.020
Cancer Radiothérapie41.020
Epi Info41.020
Microelectronic Engineering41.020
Optical Switching and Networking41.020
Journal of Communication Disorders41.020
Biological Journal of the Linnean Society41.020
Agricultural Systems41.020
Applied Catalysis A: General41.020
Applied Clay Science41.020
International Review of Cytology41.020
International Journal of Obstetric Anesthesia41.020
Nuclear Physics B41.020
Annales pharmaceutiques françaises41.020
Coordination Chemistry Reviews41.020
Food Chemistry41.020
Journal of Molecular Structure41.020
Journal of the American Society for Mass Spectrometry41.020
Electrochemistry Communications41.020
Fuel Processing Technology41.020
Advances in Cancer Research41.020
Journal of Fluorine Chemistry41.020
Journal of Nutrition41.020
Journal of Pharmaceutical Sciences41.020
Microporous and Mesoporous Materials41.020
Progress in Solid State Chemistry41.020
Radiation Physics and Chemistry41.020
Vibrational Spectroscopy41.020
Physiology & Behavior41.020
Vacuum41.020
Computers and Electronics in Agriculture41.020
Advances in Mathematics41.020
American Journal of Preventive Medicine41.020
Brain Research41.020
British Journal of Dermatology41.020
China Economic Review41.020
Cultural Diversity and Ethnic Minority Psychology41.020
Duke University Health System41.020
Early Childhood Research Quarterly41.020
Experimental Hematology41.020
Geochimica et Cosmochimica Acta41.020
The Journal of Biochemistry41.020
Journal of Memory and Language41.020
Journal of Second Language Writing41.020
Journal of Sound and Vibration41.020
Journal of the Academy of Nutrition and Dietetics41.020
Laboratory Investigation41.020
Learning and Individual Differences41.020
Magnetic Resonance Imaging41.020
Museum Management and Curatorship41.020
Personality and Individual Differences41.020
Preventing Chronic Disease41.020
Quaternary Research41.020
Transplantation Proceedings41.020
Finite Elements in Analysis and Design41.020
Linear Algebra and its Applications41.020
Annales de l'Institut Henri Poincare C41.020
Applied Mathematics Letters41.020
Applied Numerical Mathematics41.020
Current Opinion in Genetics & Development41.020
Journal of Fluency Disorders41.020
Nonlinear Analysis41.020
Nuclear Instruments & Methods in Physics Research B41.020
Seminars in Cell & Developmental Biology41.020
Systems & Control Letters41.020
NeuroToxicology41.020
Differential Geometry and its Applications41.020
Journal of Combinatorial Theory, Series B41.020
Journal of Mathematical Analysis and Applications41.020
Journal of Web Semantics41.020
Pathophysiology41.020
BJOG: an International Journal of Obstetrics and Gynaecology41.020
Archives of Gerontology and Geriatrics41.020
Cryptogamie Bryologie41.020
Advances in Marine Biology41.020
BBA: Molecular Basis of Disease41.020
Global Finance Journal41.020
Advances in Carbohydrate Chemistry and Biochemistry41.020
Brain and Development41.020
Cryptogamie Algologie41.020
Aggression and Violent Behavior41.020
Archives of Clinical Neuropsychology41.020
Pediatric Neurology41.020
General Hospital Psychiatry41.020
Comparative Immunology, Microbiology & Infectious Diseases41.020
Advances in Applied Microbiology41.020
Optometry - Journal of the American Optometric Association41.020
I C E S Journal of Marine Science41.020
Journal of Policy Modeling41.020
Best Practice and Research: Clinical Gastroenterology41.020
International Journal of Law and Psychiatry41.020
Prostaglandins and Other Lipid Mediators41.020
Building and Environment41.020
Industrial Marketing Management41.020
Meat Science41.020
Research in Organizational Behavior41.020
Fish and Shellfish Immunology41.020
Journal of Immunological Methods41.020
European Journal of Cardiovascular Nursing41.020
Human Pathology41.020
Comparative Biochemistry and Physiology. Part A: Molecular and Integrative Physiology41.020
The History of the Family41.020
Journal of Environmental Management41.020
Insight41.020
Business Horizons41.020
Computers in Human Behavior41.020
Government Information Quarterly41.020
Linguistics and Education41.020
Cryptogamie Mycologie41.020
Behaviour Research and Therapy41.020
Advances in Botanical Research41.020
Comptes Rendus. Géoscience41.020
Policy and Society41.020
Socio-Economic Planning Sciences41.020
Organizational Dynamics41.020
The American Journal of Surgery41.020
Clinical Neurophysiology41.020
Ocean Engineering41.020
International Review of Law and Economics41.020
Nuclear Physics B - Proceedings Supplements41.020
Revue Europeene de Psychologie Appliquee41.020
Computers & Graphics41.020
Journal of African Earth Sciences41.020
Annual Reports in Medicinal Chemistry41.020
Comparative Biochemistry and Physiology. Part D: Genomics and Proteomics41.020
European Journal of Mechanics A - Solids41.020
Computers and Composition41.020
Review of Financial Economics41.020
Maturitas41.020
Financial Services Review41.020
Mechanics Research Communications41.020
Journal of Cultural Heritage41.020
Clinical Imaging41.020
Journal of Environmental Sciences41.020
Journal of Clinical Lipidology41.020
Journal of Orthopaedics, Trauma and Rehabilitation41.020
Ticks and Tick-borne Diseases41.020
The Electricity Journal41.020
Social Science Research41.020
Archives of Cardiovascular Diseases Supplements41.020
National Survey of Family Growth41.020
National Vital Statistics System41.020
NIOSH Power Tools Database41.020
UCLA Health System41.020
NewYork-Presbyterian Westchester41.020
Advances in Nutrition41.020
Morbidity and Mortality Weekly Report: Recommendations and Reports41.020
Filtration & Separation41.020
Fundamental and Applied Toxicology41.020
Journal of the Less Common Metals41.020
Scripta Metallurgica41.020
Diseases of the chest41.020
Chemical health & safety American Chemical Society, Division of Chemical Health and Safety41.020
Revista paulista de pediatria : orgão oficial da Sociedade de Pediatria de São Paulo41.020
Behavioral Biology41.020
Cell Biology International Reports41.020
Vital & health statistics. Series 3, Analytical and epidemiological studies41.020
Prostate international41.020
Clinical neurosurgery41.020
The Lancet Psychiatry41.020
Advances in food research41.020
Science in China. Series B, Chemistry, life sciences & earth sciences41.020
Genetic analysis, techniques and applications41.020
Journal of the American Pharmaceutical Association41.020
Vital and health statistics. Series 3, Analytical studies41.020
Vital and health statistics. Ser. 4, Documents and committee reports41.020
Vital and health statistics. Series 13, Data from the National Health Survey41.020
Journal of epilepsy41.020
Ethology and sociobiology41.020
Aging trends (Hyattsville, Md.)41.020
Clinical microbiology newsletter41.020
NCHS data brief41.020
Journal of Verbal Learning and Verbal Behavior41.020
Paediatrics and Child Health41.020
The Lancet: Diabetes & Endocrinology41.020
Sexual medicine41.020
Avian Research41.020
Sexual medicine reviews41.020
Cell Chemical Biology41.020
MMWR supplements41.020
Operative neurosurgery (Hagerstown, Md.)41.020
Clinical neurophysiology practice41.020
Information and control41.020
Studies in Logic and the Foundations of Mathematics41.020
Computing systems in engineering : an international journal41.020
National Center for Emerging and Zoonotic Infectious Diseases41.020
Division of Parasitic Diseases and Malaria41.020
Fertility Center of San Antonio41.020
San Diego Fertility Center41.020
Chronic Disease Prevention and Health Promotion41.020
Fertility Center of Las Vegas41.020
Shady Grove Fertility Center41.020
Cooper Health System41.020
The Journal of Finance and Data Science41.020
New Hope Fertility Center41.020
Johns Hopkins Medicine41.020
Chronic Diseases and Translational Medicine41.020
World Journal of Otorhinolaryngology-Head and Neck Surgery41.020
Journal of Urban Management41.020
Journal of Asian Ceramic Societies41.020
Climate Risk Management41.020
Information Processing in Agriculture41.020
Advances in Inorganic Chemistry and Radiochemistry41.020
Fish Physiology41.020
Computer Vision, Graphics, and Image Processing41.020
Network Security41.020
Inorganic and Nuclear Chemistry Letters41.020
Inorganica Chimica Acta Reviews41.020
Information Storage and Retrieval41.020
Biometric Technology Today41.020
Membrane Technology41.020
Filtration Industry Analyst41.020
Fuel Cells Bulletin41.020
Journal of Patient Safety & Infection Control41.020
Pump Industry Analyst41.020
Space Research Today41.020
World Pumps41.020
Biology Methods and Protocols41.020
Christopher R. Conley41.020
assisted reproductive technology40.004
Embryo transfer by reproductive endocrinology fellows vs attending physicians: are live birth rates comparable?40.004
fertility clinic34.503
Money Management International34.503
Impact of men's dairy intake on assisted reproductive technology outcomes among couples attending a fertility clinic34.503
Predictors of pregnancy and live-birth in couples with unexplained infertility after ovarian stimulation-intrauterine insemination34.503
A global perspective on assisted reproductive technology fertility treatment: an 8-country fertility specialist survey34.503
Preimplantation genetic testing: a Practice Committee opinion34.503
Blastocyst culture and transfer in clinical-assisted reproduction34.503
Elective single-embryo transfer34.503
Blastocyst culture and transfer in clinical-assisted reproduction: a committee opinion34.503
Embryo transfer techniques: an American Society for Reproductive Medicine survey of current Society for Assisted Reproductive Technology practices34.503
Conventional ovarian stimulation and single embryo transfer for IVF/ICSI. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos?34.503
Association of uterine fibroids and pregnancy outcomes after ovarian stimulation-intrauterine insemination for unexplained infertility.34.503
Impact of single embryo transfer policy on perinatal outcomes in fresh and frozen cycles—analysis of the Japanese Assisted Reproduction Technology registry between 2007 and 201234.503
Comparison of antimüllerian hormone levels and antral follicle count as predictor of ovarian response to controlled ovarian stimulation in good-prognosis patients at individual fertility clinics in two multicenter trials34.503
Predictive value of antral follicle count and serum anti-Müllerian hormone: Which is better for live birth prediction in patients aged over 40 with their first IVF treatment?34.503
There is no evidence that the time from egg retrieval to embryo transfer affects live birth rates in a freeze-all strategy34.503
Predictive value of anti-müllerian hormone, follicle-stimulating hormone and antral follicle count on the outcome of ovarian stimulation in women following GnRH-antagonist protocol for IVF/ET34.503
Single embryo implantation per IVF cycle: the answer to every request for assisted reproduction?34.503
The use of anti-Müllerian hormone for controlled ovarian stimulation in assisted reproductive technology, fertility assessment and -counseling34.503
Elective single embryo transfer in women less than age 38 years reduces multiple birth rates, but not live birth rates, in United States fertility clinics34.503
Anti-Mullerian Hormone (AMH) Versus Antral Follicle Count (AFC) Guided rFSH Dosing Study34.503
Effect of Addition of Aromatase Inhibitor to Ovarian Stimulation Therapy in IVF Treatment34.503
Blastocyst culture and transfer in clinical-assisted reproduction34.503
Assessment of United States fertility clinic websites according to the American Society for Reproductive Medicine (ASRM)/Society for Assisted Reproductive Technology (SART) guidelines34.503
Preimplantation genetic testing: a Practice Committee opinion34.503
Processing of semen by density gradient centrifugation selects spermatozoa with longer telomeres for assisted reproduction techniques34.503
The use of preimplantation genetic testing for aneuploidy (PGT-A): a committee opinion34.503
Blastocyst culture and transfer in clinically assisted reproduction: a committee opinion34.503
Androgenicity and fertility treatment in women with unexplained infertility34.503
Evaluating the benefit of measuring serum progesterone prior to the administration of HCG: effect of the duration of late-follicular elevated progesterone following ovarian stimulation on fresh embryo transfer live birth rates34.503
Vitamin D Deficiency Is Associated With Poor Ovarian Stimulation Outcome in PCOS but Not Unexplained Infertility34.503
Endometrial thickness after ovarian stimulation with gonadotropin, clomiphene, or letrozole for unexplained infertility, and association with treatment outcomes34.503
Outcome of mock embryo transfer before the first IVF cycle: A randomized control trial34.503
in vitro fertilization27.302
Journal of Assisted Reproduction and Genetics27.302
Financial Counseling and Planning27.302
Reproductive Medicine and Biology27.302
Naprotechnology27.302
Semen analysis and fertility assessment in rabbits: statistical power and design considerations for toxicology studies27.302
Application of seminal plasma to female genital tract prior to embryo transfer in assisted reproductive technology cycles (IVF, ICSI and frozen embryo transfer)27.302
Post-embryo transfer interventions for assisted reproduction technology cycles27.302
Cleavage stage versus blastocyst stage embryo transfer in assisted reproductive technology27.302
Recombinant versus urinary gonadotrophin for ovarian stimulation in assisted reproductive technology cycles27.302
Cleavage stage versus blastocyst stage embryo transfer in assisted reproductive technology27.302
Soft versus firm embryo transfer catheters for assisted reproductive technology27.302
Recombinant versus urinary follicle stimulating hormone for ovarian stimulation in assisted reproduction cycles27.302
Journal of Experimental & Clinical Assisted Reproduction: shaping the future of research and practice in reproductive endocrinology/infertility27.302
The role of aromatase inhibitors in ameliorating deleterious effects of ovarian stimulation on outcome of infertility treatment27.302
Cleavage stage versus blastocyst stage embryo transfer in assisted reproductive technology27.302
<i>In vitro</i> fertilization in Japan — Early days of <i>in vitro</i> fertilization and embryo transfer and future prospects for assisted reproductive technology —27.302
Q2834460527.302
Fertility-related quality of life from two RCT cohorts with infertility: unexplained infertility and polycystic ovary syndrome.27.302
Letrozole, Gonadotropin, or Clomiphene for Unexplained Infertility27.302
Assessment of multiple intrauterine gestations from ovarian stimulation (AMIGOS) trial: baseline characteristics27.302
Predictors of participant retention in infertility treatment trials27.302
Outcomes and Recommendations of an Indian Expert Panel for Improved Practice in Controlled Ovarian Stimulation for Assisted Reproductive Technology.27.302
Risk of major congenital anomalies after assisted hatching: analysis of three-year data from the national assisted reproduction registry in Japan27.302
The role of assisted hatching in in vitro fertilization: a review of the literature. A committee opinion27.302
Pregnancy outcomes after assisted reproductive technology27.302
Human spermatozoa ultrastructure assessment in the infertility treatment by assisted reproduction technique27.302
Increasing and decreasing factors of hope in infertile women with failure in infertility treatment: A phenomenology study27.302
The status of assisted reproductive technology in Korea in 201227.302
Recombinant human follicle-stimulating hormone (r-hFSH) plus recombinant luteinizing hormone versus r-hFSH alone for ovarian stimulation during assisted reproductive technology: systematic review and meta-analysis.27.302
Impact of Endometrial Preparation Protocols for Frozen Embryo Transfer on Live Birth Rates27.302
Assisted reproduction-in vitro fertilization success is improved by ovarian stimulation with exogenous gonadotropins and pituitary suppression with gonadotropin-releasing hormone analogues27.302
Corifollitropin alfa compared to daily rFSH or HP-HMG in GnRH antagonist controlled ovarian stimulation protocol for patients undergoing assisted reproduction.27.302
The incidence of monozygotic twinning in assisted reproductive technology: Analysis based on results from the 2010 Japanese ART national registry27.302
Follicle-stimulating hormone and human menopausal gonadotropin for ovarian stimulation in assisted reproduction cycles27.302
A randomized clinical trial to determine optimal infertility treatment in older couples: the Forty and Over Treatment Trial (FORT-T)27.302
Recombinant versus urinary follicle stimulating hormone for ovarian stimulation in assisted reproduction cycles.27.302
Minimal ovarian stimulation (mini-IVF) for IVF utilizing vitrification and cryopreserved embryo transfer27.302
The outcome of infertility treatment in patients undergoing assisted reproductive technology after conservative therapy for endometrial cancer27.302
Is tubal embryo transfer of any value? A meta-analysis and comparison with the Society for Assisted Reproductive Technology database27.302
The inSIGHT study: costs and effects of routine hysteroscopy prior to a first IVF treatment cycle. A randomised controlled trial27.302
Factors influencing pregnancy rates with a combined clomiphene citrate/gonadotropin protocol for non-assisted reproductive technology fertility treatment27.302
Updated meta-analysis of recombinant follicle-stimulating hormone (FSH) versus urinary FSH for ovarian stimulation in assisted reproduction27.302
Effect of cell phone usage on semen analysis in men attending infertility clinic: an observational study27.302
Access to fertility treatment by gays, lesbians, and unmarried persons: a committee opinion27.302
Risk of breast cancer following fertility treatment—A registry based cohort study of parous women in Norway27.302
Semen Analysis: A Review of Samples from 225 Men Seen at an Infertility Clinic27.302
A healthy delivery of twins by assisted reproduction followed by preimplantation genetic screening in a woman with X-linked dominant incontinentia pigmenti27.302
Fertility treatment when the prognosis is very poor or futile27.302
Access to fertility treatment by gays, lesbians, and unmarried persons27.302
Prognostic value of first IVF cycle on success of a subsequent cycle27.302
Hysteroscopy prior to the first IVF cycle: A systematic review and meta-analysis27.302
Individualised controlled ovarian stimulation (iCOS): maximising success rates for assisted reproductive technology patients27.302
The use of luteinising hormone releasing hormone agonists for ovarian stimulation in assisted reproductive technology27.302
Application of a validated prediction model for in vitro fertilization: comparison of live birth rates and multiple birth rates with 1 embryo transferred over 2 cycles vs 2 embryos in 1 cycle27.302
Thromboembolism after ovarian stimulation: successful management of a woman with superior sagittal sinus thrombosis after IVF and embryo transfer: Case report27.302
Choice of ovarian stimulation regimens in assisted reproduction: finding the thread in the gonadotropin maze27.302
The Management of Uterine Fibroids in Women With Otherwise Unexplained Infertility27.302
What is the most relevant standard of success in assisted reproduction?: challenges in measuring and reporting success rates for assisted reproductive technology treatments: what is optimal?27.302
What is the most relevant standard of success in assisted reproduction? Redefining success in the context of elective single embryo transfer: evidence, intuition and financial reality27.302
Effectiveness and treatment for unexplained infertility27.302
Patients undergoing frozen-thawed embryo transfer have similar live birth rates in spontaneous and artificial cycles27.302
The best infertility treatment for vasectomized men: assisted reproduction or vasectomy reversal?27.302
Effect of Embryo Banking on U.S. National Assisted Reproductive Technology Live Birth Rates27.302
Human recombinant follicle stimulating hormone (rFSH) compared to urinary human menopausal gonadotropin (HMG) for ovarian stimulation in assisted reproduction: a literature review and cost evaluation27.302
Gonadotrophin ovarian stimulation and intrauterine insemination for unexplained infertility27.302
Minimal ovarian stimulation combined with elective single embryo transfer policy: age-specific results of a large, single-centre, Japanese cohort27.302
The association of serum estradiol level with outcomes of clomiphene citrate/human menopausal gonadotropin ovarian stimulation for in vitro fertilization and embryo transfer27.302
Effect of endometrial biopsy on intrauterine insemination outcome in controlled ovarian stimulation cycle27.302
Sperm chromatin structure assay results in Nigerian men with unexplained infertility27.302
Embryo transfer practices and multiple births resulting from assisted reproductive technology: an opportunity for prevention27.302
Soft versus firm embryo transfer catheters for assisted reproduction: a systematic review and meta-analysis27.302
Conservative management versus aspiration of functional ovarian cysts before ovarian stimulation for assisted reproduction27.302
Treatment policy after poor fertilization in the first IVF cycle27.302
Firm embryo transfer catheters for assisted reproduction: a systematic review and meta-analysis using direct and adjusted indirect comparisons27.302
Embryo transfer in days 2 to 4 following intracytoplasmic sperm injection: a prospective cohort study27.302
Age-Related Normogram for Ovarian Antral Follicle Count in Women with Polycystic Ovary Syndrome and Comparison with Age Matched Controls Using Magnetic Resonance Imaging27.302
Genetic considerations related to intracytoplasmic sperm injection (ICSI).27.302
Guidelines for reducing the risk of viral transmission during fertility treatment27.302
Round spermatid nucleus injection (ROSNI).27.302
Comparing blastocyst quality and live birth rates of intravaginal culture using INVOcell™ to traditional in vitro incubation in a randomized open-label prospective controlled trial27.302
Computer-assisted semen analysis systems: comparison with routine evaluation and prognostic value in male fertility and assisted reproduction27.302
Current status of assisted reproductive technology in Korea, 201127.302
Reluctance of medical professionals in adopting natural-cycle and minimal ovarian stimulation protocols in human clinical assisted reproduction27.302
Use of letrozole in assisted reproduction: a systematic review and meta-analysis.27.302
A common polymorphic allele of the LH beta-subunit gene is associated with higher exogenous FSH consumption during controlled ovarian stimulation for assisted reproductive technology27.302
The significance of serum anti-Müllerian hormone (AMH) levels in patients over age 40 in first IVF treatment27.302
Estimating rates of multiple gestation pregnancies: sample size calculation from the assessment of multiple intrauterine gestations from ovarian stimulation (AMIGOS) trial27.302
Anti-mullerian hormone and antral follicle count as predictors of ovarian response in assisted reproduction27.302
Comparison of the GnRH agonist and antagonist protocol on the same patients in assisted reproduction during controlled ovarian stimulation cycles27.302
Endometrial morphology and modulation of hormone receptors during ovarian stimulation for assisted reproductive technology cycles27.302
Optimizing natural fertility27.302
Assisted reproductive technology use, embryo transfer practices, and birth outcomes after infertility insurance mandates: New Jersey and Connecticut27.302
Endometrial signaling pathways during ovarian stimulation for assisted reproduction technology27.302
Costs of achieving live birth from assisted reproductive technology: a comparison of sequential single and double embryo transfer approaches27.302
Validation of infertility treatment and assisted reproductive technology use on the birth certificate in eight states27.302
Economics of assisted reproduction: access to fertility treatments and valuing live births in economic terms27.302
Attitudes towards single embryo transfer, twin and higher order pregnancies in patients undergoing infertility treatment: a review27.302
Human immunodeficiency virus and infertility treatment27.302
Corifollitropin alfa: a review of its use in controlled ovarian stimulation for assisted reproduction27.302
Does exogenous LH in ovarian stimulation improve assisted reproduction success? An appraisal of the literature27.302
Recombinant versus urinary gonadotrophin for ovarian stimulation in assisted reproductive technology cycles. A Cochrane review.27.302
Intracytoplasmic sperm injection (ICSI) for non-male factor infertility: a committee opinion27.302
In vitro maturation: a committee opinion27.302
The wobbly evidence base of reproductive medicine27.302
Body mass index in relation to semen quality and reproductive hormones in New Zealand men: a cross-sectional study in fertility clinics27.302
Melatonin supplementation during controlled ovarian stimulation for women undergoing assisted reproductive technology: systematic review and meta-analysis of randomized controlled trials27.302
Misconduct in third-party assisted reproduction: a committee opinion27.302
VACTERL association with hydrocephalus in a fetus conceived by in vitro fertilization and embryo transfer27.302
Cryopreservation and delayed embryo transfer-assisted reproductive technology registry and reporting implications27.302
Role of assisted hatching in in vitro fertilization: a guideline27.302
Recommended practices for the management of embryology, andrology, and endocrinology laboratories: a committee opinion27.302
Assisted reproductive technology - IVF treatment in Ireland: A study of couples with successful outcomes27.302
Does weight loss in overweight or obese women improve fertility treatment outcomes? A systematic review27.302
Methods employed to overcome difficult embryo transfer during assisted reproduction treatment27.302
Role of tubal surgery in the era of assisted reproductive technology: a committee opinion27.302
A comparison of live birth rates and cumulative ongoing pregnancy rates between Europe and North America after ovarian stimulation with corifollitropin alfa or recombinant follicle-stimulating hormone27.302
Evidence of impaired endometrial receptivity after ovarian stimulation for in vitro fertilization: a prospective randomized trial comparing fresh and frozen–thawed embryo transfer in normal responders27.302
Comparison of follicular fluid IGF-I, IGF-II, IGFBP-3, IGFBP-4 and PAPP-A concentrations and their ratios between GnRH agonist and GnRH antagonist protocols for controlled ovarian stimulation in IVF-embryo transfer patients27.302
Role of the mental health professional in education and support of the medical staff27.302
Subclinical hypothyroidism in the infertile female population: a guideline27.302
Comparison of neonatal outcomes following progesterone use during ovarian stimulation with frozen-thawed embryo transfer27.302
Assisted reproductive technology in Australia and New Zealand: cumulative live birth rates as measures of success27.302
Correct coding for laboratory procedures during assisted reproductive technology cycles27.302
Lesbian, gay, bisexual, transgender content on reproductive endocrinology and infertility clinic websites27.302
The effect of peri-implantation administration of uterine relaxing agents in assisted reproduction treatment cycles: a systematic review and meta-analysis27.302
Maternal Racial and Ethnic Disparities in Neonatal Birth Outcomes With and Without Assisted Reproduction27.302
Sexual function in infertile women with polycystic ovary syndrome and unexplained infertility27.302
Factors predicting double embryo implantation following double embryo transfer in assisted reproductive technology: implications for elective single embryo transfer27.302
Guidance on the limits to the number of embryos to transfer: a committee opinion27.302
Perinatal outcomes among singletons after assisted reproductive technology with single-embryo or double-embryo transfer versus no assisted reproductive technology27.302
Embryo transfer simulation improves pregnancy rates and decreases time to proficiency in Reproductive Endocrinology and Infertility fellow embryo transfers27.302
Practice patterns, satisfaction, and demographics of reproductive endocrinologists: results of the 2014 Society for Reproductive Endocrinology and Infertility Workforce Survey27.302
The role of steroid hormone supplementation in non-assisted reproductive technology treatments for unexplained infertility27.302
Performing the embryo transfer: a guideline27.302
Effect of smoking on ovarian reserve and ovarian stimulation in in- vitro fertilization and embryo transfer27.302
Population-based Semen Analysis Results and Fertility Among Patients With Inflammatory Bowel Disease: Results From Subfertility Health Assisted Reproduction and the Environment (SHARE) Study27.302
Assisted reproductive technology: public funding and the voluntary shift to single embryo transfer in Australia27.302
Couples with unexplained subfertility and unfavorable prognosis: a randomized pilot trial comparing the effectiveness of in vitro fertilization with elective single embryo transfer versus intrauterine insemination with controlled ovarian stimulation27.302
Ovarian stimulation with clomiphene and/or human menopausal gonadotropin (HMG) for in vitro fertilization (IVF) and embryo transfer (ET).27.302
Assisted reproductive techniques in Latin America: the Latin American Registry, 201327.302
Assisted reproductive medicine in Poland --Fertility and Sterility Special Interest Group of the Polish Gynaecological Society (SPiN PTG) 2012 report27.302
Endometrial thickness significantly affects clinical pregnancy and live birth rates in frozen-thawed embryo transfer cycles27.302
Luteal-phase ovarian stimulation is a feasible method for poor ovarian responders undergoing in vitro fertilization/intracytoplasmic sperm injection-embryo transfer treatment compared to a GnRH antagonist protocol: A retrospective study27.302
Determining the need for rescue intracytoplasmic sperm injection in partial fertilisation failure during a conventional IVF cycle27.302
Pain during embryo transfer is independently associated with clinical pregnancy in fresh/frozen assisted reproductive technology cycles27.302
Position statement on West Nile virus: a committee opinion27.302
Catastrophic payment for assisted reproduction techniques with conventional ovarian stimulation in the public health sector of South Africa: frequency and coping strategies27.302
Assisted reproduction policies in Israel: a retrospective analysis of in vitro fertilization–embryo transfer27.302
How do cumulative live birth rates and cumulative multiple live birth rates over complete courses of assisted reproductive technology treatment per woman compare among registries?27.302
Recommendations for practices utilizing gestational carriers: a committee opinion27.302
Is there an effect of thyroid autoimmunity on the outcomes of assisted reproduction?27.302
American Society for Reproductive Medicine/Society for Assisted Reproductive Technology position statement on West Nile virus27.302
Predictive values of anti-müllerian hormone, antral follicle count and ovarian response prediction index (ORPI) for assisted reproductive technology outcomes27.302
Live birth rates are satisfactory following multiple IVF treatment cycles in poor prognosis patients.27.302
American Society for Reproductive Medicine/Society for Assisted Reproductive Technology position statement on West Nile virus27.302
Risk of ectopic pregnancy is linked to endometrial thickness in a retrospective cohort study of 8120 assisted reproduction technology cycles27.302
American Society for Reproductive Medicine/Society for Assisted Reproductive Technology position statement on West Nile Virus27.302
Cumulative number and morphological score of embryos resulting in success: realistic expectations from in vitro fertilization-embryo transfer27.302
Physical health of singleton children born after frozen embryo transfer using slow freezing: a 3-year follow-up study27.302
Cycle-to-cycle variation in utero-ovarian hemodynamic indices in ovarian stimulation and natural cycles of the same women and its effect on the outcome of assisted reproduction treatment.27.302
The relationship between the changes in the level of progesterone and the outcome ofin vitrofertilization-embryo transfer27.302
Luteinizing hormone-releasing hormone agonists for ovarian stimulation in assisted reproduction27.302
Increased risk of early pregnancy loss by profound suppression of luteinizing hormone during ovarian stimulation in normogonadotrophic women undergoing assisted reproduction27.302
Position on reproductive donors and smallpox vaccine: a committee opinion27.302
Ovarian stimulation for assisted reproduction27.302
Hormonal and Clinical Predictors for Post-egg Retrieval Pain in Women Undergoing Assisted Reproductive Technology Procedures.27.302
Current differences and consequences of legislation on practice of assisted reproductive technology in the Nordic countries. The Nordic Committee on Assisted Reproduction of the Scandinavian Federation of Societies of Obstetrics and Gynecology27.302
Mole modifications following controlled ovarian stimulation for assisted reproduction technologies27.302
Comparison of live-birth defects after luteal-phase ovarian stimulation vs. conventional ovarian stimulation for in vitro fertilization and vitrified embryo transfer cycles27.302
Human immunodeficiency virus (HIV) and infertility treatment: a committee opinion27.302
Ovarian stimulation in assisted reproduction.27.302
Safety in reproductive medicine: breadth, depth and discovery27.302
Cumulative live birth rates after fresh and vitrified cleavage-stage versus blastocyst-stage embryo transfer in the first treatment cycle.27.302
Mature oocyte cryopreservation: a guideline27.302
Neonatal outcome and birth defects in 6623 singletons born following minimal ovarian stimulation and vitrified versus fresh single embryo transfer27.302
Lapse in embryo transfer training does not negatively affect clinical pregnancy rates for reproductive endocrinology and infertility fellows27.302
Recommendations for development of an emergency plan for in vitro fertilization programs: a committee opinion27.302
Recommendations for development of an emergency plan for in vitro fertilization programs: a committee opinion27.302
Guidelines for development of an emergency plan for in vitro fertilization programs27.302
Ovarian stimulation and corpus luteum function in human in vitro fertilization and embryo transfer27.302
Fertility Treatments in the United States: Improving Access and Outcomes27.302
Preprogrammed, unmonitored ovarian stimulation reduces expense without compromising the outcome of assisted reproduction27.302
Day-5 inhibin B serum concentrations and antral follicle count as predictors of ovarian response and live birth in assisted reproduction cycles stimulated with gonadotropin after pituitary suppression27.302
Delivery rates following IVF treatment, using two recombinant FSH preparations for ovarian stimulation27.302
IVF Treatment and Single Embryo Transfer27.302
Effect of high-dose estrogen in luteal phase support on live birth rates after assisted reproduction treatment cycles27.302
A randomised controlled trial of 300 versus 225 IU recombinant FSH for ovarian stimulation in predicted normal responders by antral follicle count27.302
Lyophilised hMG versus rFSH in women with unexplained infertility undergoing a controlled ovarian stimulation with intrauterine insemination: a prospective, randomised study.27.302
First live birth following IVF-embryo transfer and use of GnRHa alone for ovarian stimulation27.302
Refuting a misguided campaign against the goal of single-embryo transfer and singleton birth in assisted reproduction27.302
An effective alternative to only gonadotrophin for controlled ovarian stimulation in unexplained infertility patients undergoing intra-uterine insemination: a clinical trial27.302
Comparison of aneuploidy, pregnancy and live birth rates between day 5 and day 6 blastocysts27.302
Usage of herbal medications in patients undergoing IVF treatment in an Irish infertility treatment unit27.302
Repetitive oocyte donation: a committee opinion27.302
Optimizing natural fertility: a committee opinion27.302
Life after unsuccessful IVF treatment in an assisted reproduction unit: a qualitative analysis of gains through loss among Chinese persons in Hong Kong.27.302
Suppression of LH during ovarian stimulation: analysing threshold values and effects on ovarian response and the outcome of assisted reproduction in down-regulated women stimulated with recombinant FSH.27.302
Recommendations for reducing the risk of viral transmission during fertility treatment with the use of autologous gametes: a committee opinion27.302
Estimation of the Contribution of Assisted and Non-Assisted Reproductive Technology Fertility Treatments to Multiple Births During the Past 30 Years in Japan: 1979–200827.302
Impact of pituitary suppression on antral follicle count and oocyte recovery after ovarian stimulation27.302
Perinatal outcomes after assisted reproductive technology treatment in Australia and New Zealand: single versus double embryo transfer.27.302
Role of semen analysis in subfertile couples27.302
The relationship between endogenous oestradiol and vitamin D3 metabolites in serum and follicular fluid during ovarian stimulation for in-vitro fertilization and embryo transfer27.302
The effect of smoking on infertility treatment in women undergoing assisted reproduction cycles27.302
Follicular fluid-induced acrosome reaction distinguishes a subgroup of men with unexplained infertility not identified by semen analysis27.302
Personal experience with ovarian stimulation in an in vitro fertilization and embryo transfer program27.302
The serum concentration of estradiol after embryo transfer and the decline from preovulatory levels may influence the success of IVF treatment27.302
Aromatase inhibition reduces gonadotrophin dose required for controlled ovarian stimulation in women with unexplained infertility27.302
LH serum levels during ovarian stimulation as predictors of ovarian response and assisted reproduction outcome in down-regulated women stimulated with recombinant FSH.27.302
Effect of ovarian stimulation on plasma lipid and apolipoprotein concentrations in a population of infertile women undergoing IVF/embryo transfer27.302
IVF with planned single-embryo transfer versus IUI with ovarian stimulation in couples with unexplained subfertility: an economic analysis27.302
Ovarian stimulation for in vitro fertilization and embryo transfer, human menopausal gonadotropin versus pure human follicle stimulating hormone: a randomized prospective study.27.302
Half-dose depot triptorelin in pituitary suppression for multiple ovarian stimulation in assisted reproduction technology: a randomized study27.302
Comparison of clinical outcome of mild-stimulation and conventional ovarian stimulation in in vitro fertilization-embryo transfer (IVF-ET)27.302
Effect of pituitary downregulation on antral follicle count, ovarian volume and stromal blood flow measured by three-dimensional ultrasound with power Doppler prior to ovarian stimulation27.302
Antimüllerian hormone levels and antral follicle counts are not reduced compared with community controls in patients with rigorously defined unexplained infertility27.302
Perspective on in vitro fertilization and embryo transfer. Stimulus for biomedical research in reproductive medicine27.302
Evidence-based medicine and the role of the private sector in assisted reproduction: a response to Dr Fishel’s commentary ‘Evidenced-based medicine and the role of the National Health Service in assisted reproduction’27.302
Paternal body mass index is associated with decreased blastocyst development and reduced live birth rates following assisted reproductive technology27.302
Risk-sharing or refund programs in assisted reproduction: a committee opinion27.302
Advantages of recombinant follicle-stimulating hormone over human menopausal gonadotropin for ovarian stimulation in intrauterine insemination: a randomized clinical trial in unexplained infertility.27.302
Expected poor responders on the basis of an antral follicle count do not benefit from a higher starting dose of gonadotrophins in IVF treatment: a randomized controlled trial27.302
Anti-Müllerian hormone and antral follicle count for prediction of ovarian stimulation response in polycystic ovary syndrome.27.302
Antral follicle count and FSH concentration after clomiphene citrate challenge test in the prediction of ovarian response during IVF treatment27.302
Efficacy and safety of frozen-thawed embryo transfer in women aged 35 to 42 years from the PURSUE randomized clinical trial27.302
Society for Assisted Reproductive Technology position statement on donor suitability of recipients of smallpox vaccine (vaccinia virus).27.302
Society for Assisted Reproductive Technology position statement on donor suitability of recipients of smallpox vaccine (vaccinia virus).27.302
Human immunodeficiency virus and infertility treatment27.302
Society for assisted reproductive technology position statement on donor suitability of recipients of smallpox vaccine (vaccinia virus).27.302
Society for assisted reproductive technology position statement on donor suitability of recipients of smallpox vaccine (vaccinia virus).27.302
Human immunodeficiency virus and infertility treatment27.302
Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation27.302
A Study of Controlled Ovarian Stimulation with Clomiphene Citrate or Letrozole in Combination with Gonadotropins and IUI in Unexplained Infertility27.302
Response to 'Is it safe to perform a controlled ovarian stimulation for assisted reproduction in young breast cancer survivors?'.27.302
Guidelines on number of embryos transferred27.302
Public policy aspects of assisted reproduction. Vth World Congress, IVF and embryo transfer27.302
Progesterone supplementation during the luteal phase and in early pregnancy in the treatment of infertility: an educational bulletin27.302
Prognostic indicators of assisted reproduction technology outcomes of cycles with ultralow serum antimüllerian hormone: a multivariate analysis of over 5,000 autologous cycles from the Society for Assisted Reproductive Technology Clinic Outcome Repo27.302
Ovarian stimulation, egg aspiration, in vitro fertilization and embryo transfer in the baboon (Papio anubis): a pilot project at the Institute of Primate Research, Nairobi, Kenya27.302
Trends and factors associated with the Day 5 embryo transfer, assisted reproductive technology surveillance, USA, 2001-2009.27.302
The effect of elevated progesterone levels before oocyte retrieval in women undergoing ovarian stimulation for IVF treatment on the genomic profile of peri-implantation endometrium.27.302
Estimating live birth rates after ovulation induction in polycystic ovary syndrome: sample size calculations for the pregnancy in polycystic ovary syndrome trial27.302
Evolution of a reproductive endocrinologist: the Society for Reproductive Endocrinology and Infertility fellows retreat and preliminary results of manpower survey27.302
Embryo transfer practices in the United States: a survey of clinics registered with the Society for Assisted Reproductive Technology27.302
Posthumous assisted reproduction: a survey of attitudes of couples seeking fertility treatment and the degree of agreement between intimate partners27.302
Viral infections among couples for assisted reproduction in a fertility clinic in Nigeria.27.302
Factors associated with dizygotic twinning after IVF treatment with double embryo transfer27.302
Antral follicle count, anti-mullerian hormone and inhibin B: predictors of ovarian response in assisted reproductive technology?27.302
Treatment period and medical care costs to achieve the first live birth by assisted reproductive technology are lower in the single embryo transfer period than in the double embryo transfer period: a retrospective analysis of women younger than 40 y27.302
The significance of antral follicle count in controlled ovarian stimulation and intrauterine insemination27.302
An analysis of the impact of embryo transfer difficulty on live birth rates, using a standardised grading system27.302
No increase in autism-associated genetic events in children conceived by assisted reproduction27.302
Not all twins are monozygotic after elective single embryo transfer: analysis of 32,600 elective single embryo transfer cycles as reported to the Society for Assisted Reproductive Technology27.302
Intrauterine insemination with ovarian stimulation versus expectant management for unexplained infertility (TUI): a pragmatic, open-label, randomised, controlled, two-centre trial27.302
Are attachment dimensions associated with infertility-related stress in couples undergoing their first IVF treatment? A study on the individual and cross-partner effect.27.302
Preconceptional antithyroid peroxidase antibodies, but not thyroid-stimulating hormone, are associated with decreased live birth rates in infertile women27.302
Assisted reproductive technology (ART) cumulative live birth rates following preimplantation genetic diagnosis for aneuploidy (PGD-A) or morphological assessment of embryos: A cohort analysis.27.302
Stimulation of endometrium embryo transfer can improve implantation and pregnancy rates for patients undergoing assisted reproductive technology for the first time with a high-grade blastocyst27.302
Congenital Malformations in Singleton Infants Conceived by Assisted Reproductive Technologies and Singleton Infants by Natural Conception in Tehran, Iran27.302
Cumulative pregnancy and live birth rates through assisted reproduction in women 44-45 years of age: is there any hope?27.302
Does ovarian stimulation regimen affect IVF outcome? a two-centre, real-world retrospective study using predominantly cleavage-stage, single embryo transfer27.302
Association Between Pesticide Residue Intake From Consumption of Fruits and Vegetables and Pregnancy Outcomes Among Women Undergoing Infertility Treatment With Assisted Reproductive Technology27.302
The Importance of the Periconception Period: Immediate Effects in Cattle Breeding and in Assisted Reproduction Such as Artificial Insemination and Embryo Transfer27.302
Evaluation of trend in semen analysis for 11 years in subjects attending a fertility clinic in India.27.302
Provision of fertility services for women at increased risk of complications during fertility treatment or pregnancy: an Ethics Committee opinion27.302
Financial "risk-sharing" or refund programs in assisted reproduction: an Ethics Committee opinion27.302
The impact of the new Turkish regulation, imposing single embryo transfer after assisted reproduction technology, on neonatal intensive care unit utilization: a single center experience.27.302
Assisted reproductive technology in the United States: 2001 results generated from the American Society for Reproductive Medicine/Society for Assisted Reproductive Technology registry27.302
Combined advanced parental age has an additive negative effect on live birth rates-data from 4057 first IVF/ICSI cycles.27.302
Assisted reproductive technology in the United States: 2000 results generated from the American Society for Reproductive Medicine/Society for Assisted Reproductive Technology Registry27.302
Assisted reproductive technology in the United States: 1999 results generated from the American Society for Reproductive Medicine/Society for Assisted Reproductive Technology Registry27.302
Assisted reproductive technology in the United States: 1998 results generated from the American Society for Reproductive Medicine/Society for Assisted Reproductive Technology Registry27.302
A Focus on Maternal Health Before Assisted Reproduction: Results From a Pilot Survey of Canadian IVF Medical Directors27.302
Assisted reproductive technology in reproductive medicine - possibilities and limitations27.302
Reproductive Ethics in Commercial Surrogacy: Decision-Making in IVF Clinics in New Delhi, India27.302
The use of luteal-phase ovarian stimulation for poor ovarian responders undergoing in vitro fertilization/intracytoplasmic sperm injection-embryo transfer treatment27.302
Effect of premature serum progesterone rise on embryo transfer outcomes and the role of blastocyst culture and transfer in assisted reproductive technology cycles with premature progesterone rise27.302
Elevated serum estradiol levels in artificial autologous frozen embryo transfer cycles negatively impact ongoing pregnancy and live birth rates27.302
New application of dydrogesterone as a part of a progestin-primed ovarian stimulation protocol for IVF: a randomized controlled trial including 516 first IVF/ICSI cycles27.302
Do endometriomas grow during ovarian stimulation for assisted reproduction? A three-dimensional volume analysis before and after ovarian stimulation27.302
Melatonin concentration in follicular fluid is correlated with antral follicle count (AFC) and in vitro fertilization (IVF) outcomes in women undergoing assisted reproductive technology (ART) procedures.27.302
Patient and cycle characteristics predicting high pregnancy rates with single-embryo transfer: an analysis of the Society for Assisted Reproductive Technology outcomes between 2004 and 2013.27.302
Initial maternal serum human chorionic gonadotropin levels in pregnancies achieved after assisted reproductive technology are higher after preimplantation genetic screening and after frozen embryo transfer: a retrospective cohort27.302
The psychological impact of mild ovarian stimulation combined with single embryo transfer compared with conventional IVF.27.302
Cryopreserved embryo transfer: adjacent or non-adjacent to failed fresh long GnRH-agonist protocol IVF cycle27.302
Uncommon but devastating event: total fertilisation failure following intracytoplasmic sperm injection27.302
Self-operated endovaginal telemonitoring versus traditional monitoring of ovarian stimulation in assisted reproduction: an RCT27.302
Revised minimum standards for practices offering assisted reproductive technologies: a committee opinion27.302
Pregnancy rates in donor oocyte cycles compared to similar autologous in vitro fertilization cycles: an analysis of 26,457 fresh cycles from the Society for Assisted Reproductive Technology27.302
Live birth rates in Bologna poor responders treated with ovarian stimulation for IVF/ICSI.27.302
The impact of legally restricted embryo transfer and reimbursement policy on cumulative delivery rate after treatment with assisted reproduction technology27.302
Luteal-phase ovarian stimulation is feasible for producing competent oocytes in women undergoing in vitro fertilization/intracytoplasmic sperm injection treatment, with optimal pregnancy outcomes in frozen-thawed embryo transfer cycles27.302
What is the quality of information on social oocyte cryopreservation provided by websites of Society for Assisted Reproductive Technology member fertility clinics?27.302
Recommendations for gamete and embryo donation: a committee opinion27.302
Colour Doppler assessment of ascendent uterine artery perfusion in an in-vitro fertilization-embryo transfer programme after pituitary desensitization and ovarian stimulation with human recombinant follicle stimulating hormone27.302
Predicting ovarian reserve and reproductive outcome using antimüllerian hormone (AMH) and antral follicle count (AFC) in patients with previous assisted reproduction technique (ART) failure27.302
Double embryo transfer gives good pregnancy and live birth rates in poor responders with a modest increase in multiple birth rates: results from an observational study27.302
Female obesity adversely affects assisted reproductive technology (ART) pregnancy and live birth rates27.302
Randomized comparison of different ovarian stimulation regimens for assisted reproductive technology in baboons (Papio anubis).27.302
2008 Guidelines for gamete and embryo donation: a Practice Committee report27.302
Round spermatid nucleus injection (ROSNI).27.302
Revised minimum standards for practices offering assisted reproductive technologies27.302
Essential elements of informed consent for elective oocyte cryopreservation: a Practice Committee opinion27.302
Intermittent vaginal injections of gonadotrophins for ovarian stimulation in IVF treatment27.302
Guidelines for development of an emergency plan for in vitro fertilization programs27.302
Predictors of ongoing pregnancy after single-embryo transfer following mild ovarian stimulation for IVF.27.302
New alternative to infertility treatment for women without ovarian stimulation.27.302
Similar outcome for cryopreserved embryo transfer following GnRH-antagonist/GnRH-agonist, GnRH-antagonist/HCG or long protocol ovarian stimulation27.302
Increased risk of early menopausal transition and natural menopause after poor response at first IVF treatment27.302
Estimation of the contribution of non-assisted reproductive technology ovulation stimulation fertility treatments to US singleton and multiple births27.302
Assisted reproduction technique outcomes for fresh versus deferred cryopreserved day-2 embryo transfer: a retrospective matched cohort study27.302
Ovarian stimulation during assisted reproduction treatment: a comparison of recombinant and highly purified urinary human FSH. On behalf of The Feronia and Apis study group27.302
Ovarian stimulation for assisted reproduction with HMG and concomitant midcycle administration of the GnRH antagonist cetrorelix according to the multiple dose protocol: a prospective uncontrolled phase III study27.302
Ovarian stimulation in women undergoing in-vitro fertilization and embryo transfer using recombinant human follicle stimulating hormone (Gonal-F) in non-down-regulated cycles27.302
Endocrinology: Endogenous plasma growth hormone and the occurrence of pregnancies in patients undergoing in-vitro fertilization and embryo transfer with ovarian stimulation27.302
Selection of ovarian stimulation protocol is related to IVF treatment outcome in women 35 years of age and older27.302
Outcome of donor versus husband insemination in couples with unexplained infertility treated by in vitro fertilization and embryo transfer27.302
Bilateral salpingectomy does not compromise ovarian stimulation in an in-vitro fertilization/embryo transfer programme27.302
Growth hormone, oestradiol, progesterone and testosterone concentrations in follicular fluid after ovarian stimulation with various regimes for assisted reproduction27.302
Birthweight of singletons after assisted reproduction is higher after single- than after double-embryo transfer27.302
Infertility treatment strategy involving combined freeze-all embryos and single vitrified-warmed embryo transfer during hormonal replacement cycle for in vitro fertilization of women with hypogonadotropic hypogonadism27.302
Antimüllerian hormone as a predictor of live birth following assisted reproduction: an analysis of 85,062 fresh and thawed cycles from the Society for Assisted Reproductive Technology Clinic Outcome Reporting System database for 2012-2013.27.302
On the Origins of the Semen Analysis: A Close Relationship with the History of the Reproductive Medicine27.302
Role of FSHR rs6165 and ESR2 rs4986938 polymorphisms in ovarian stimulation of Iranian women who underwent assisted reproduction treatment27.302
Assisted reproductive technology : strategies of elective single embryo transfer27.302
Do trained reproductive endocrinologists perform better than their trainees? Comparing clinical pregnancy rates and live birth rates after transfer of single fresh blastocysts.27.302
Comparison of embryo transfer strategies and assisted reproduction outcome in Slovenian and cross-border patients27.302
CLINICAL ASSISTED REPRODUCTION: Comparison of Recombinant and Urinary Follicle-Stimulating Hormone Preparations in Short-Term Gonadotropin Releasing Hormone Agonist Protocol for In Vitro Fertilization-Embryo Transfer27.302
Bioethical dilemmas of assisted reproduction in the opinions of Polish women in infertility treatment: a research report27.302
Costs of medically assisted reproduction treatment at specialized fertility clinics in the Danish public health care system: results from a 5-year follow-up cohort study27.302
Fertility treatments and invasive epithelial ovarian cancer risk in Jewish Israeli BRCA1 or BRCA2 mutation carriers27.302
1995 assisted reproductive technology success rates: national summary and fertility clinic report.27.302
2006 Guidelines for Gamete and Embryo Donation27.302
Elements to be considered in obtaining informed consent for ART.27.302
Optimum number of oocytes for a successful first IVF treatment cycle27.302
Use of serum inhibin B levels at the start of ovarian stimulation and at oocyte pickup in the prediction of assisted reproduction treatment outcome27.302
Use of fetal oocytes in assisted reproduction27.302
Significant reduction of the incidence of ovarian hyperstimulation syndrome (OHSS) by using the LHRH antagonist Cetrorelix (Cetrotide) in controlled ovarian stimulation for assisted reproduction27.302
Cetrotide confirmatory trial of cetrorelix/0.25 mg in 26 women undergoing ovarian stimulation with recombinant follicle stimulating hormones for IVF, ICSI and embryo transfer (ET).27.302
Changes induced in serum protein profiles by ovarian stimulation during in-vitro fertilization--embryo transfer treatment: a comparison between conception and non-conception cycles27.302
Further observations on serial serum immunoreactive inhibin levels in the luteal phase and early gestation after ovarian stimulation for in vitro fertilization and embryo transfer27.302
Comparison of four different ovarian stimulation protocols in an in vitro fertilisation & embryo transfer programme27.302
Treatment of patients with unexplained infertility: gamete intrafallopian transfer (GIFT) versus tubal embryo transfer (TET)27.302
Optimizing natural fertility: a committee opinion27.302
Low negative affect prior to treatment is associated with a decreased chance of live birth from a first IVF cycle27.302
Expectations for success in fertility treatment involving assisted reproduction27.302
Reproductive medicine in transition: new developments in embryo transfer27.302
Efficacy of intrauterine inseminations as a training modality for performing embryo transfer in reproductive endocrinology and infertility fellowship programs.27.302
Intrauterine administration of hCG-activated autologous human peripheral blood mononuclear cells (PBMC) promotes live birth rates in frozen/thawed embryo transfer cycles of patients with repeated implantation failure27.302
Revised guidelines for human embryology and andrology laboratories27.302
Is there a need for recombinant human luteinizing hormone (lutropin alfa) supplementation in ovarian stimulation for assisted reproduction?27.302
Predictive factors and a corresponding treatment algorithm for controlled ovarian stimulation in patients treated with recombinant human follicle stimulating hormone (follitropin alfa) during assisted reproduction technology (ART) procedures. An ana27.302
AIDA for reproductive medicine and the fertility clinic27.302
Subnormal sperm parameters in conventional semen analysis are associated with discrepancies between fertilization and pregnancy rates in in-vitro fertilization and embryo transfer27.302
Selective early elimination of luteal support in assisted reproduction cycles using a gonadotropin-releasing hormone agonist during ovarian stimulation27.302
Pregnancy outcomes of PCOS overweight/obese patients after controlled ovarian stimulation with the GnRH antagonist protocol and frozen embryo transfer27.302
Live birth rates in the first complete IVF cycle among 20 687 women using a freeze-all strategy27.302
Beyond the American Society for Reproductive Medicine transfer guidelines: how many cleavage-stage embryos are safe to transfer in women ≥43 years old?27.302
Economic implications of the Society for Assisted Reproductive Technology embryo transfer guidelines: healthcare dollars saved by reducing iatrogenic triplets27.302
Reply: Models for predicting live birth before a first IVF cycle27.302
Estrous cycle staging before mating led to increased efficiency in the production of pseudopregnant recipients without negatively affecting embryo transfer in mice27.302
Anti-Müllerian hormone levels after laparoscopic cystectomy for endometriomas as a possible predictor for pregnancy in infertility treatments27.302
AIUM practice guideline for ultrasonography in reproductive medicine27.302
'Elective single embryo transfer (eSET) reduces pregnancy rates and should only be used in exceptional circumstances': AGAINST: SET maintains live birth rates and provides unique advantages27.302
Surveillance of congenital malformations in infants conceived through assisted reproductive technology or other fertility treatments27.302
Suitable fresh embryo transfer strategy for mild ovarian stimulation with clomiphene citrate27.302
Endometrial Scratch Injury Induces Higher Pregnancy Rate for Women With Unexplained Infertility Undergoing IUI With Ovarian Stimulation: A Randomized Controlled Trial27.302
Recommendations for practices utilizing gestational carriers: a committee opinion27.302
Comparison of the effect of immediate versus delayed transfer following a stimulated IVF cycle on the ongoing pregnancy rate of frozen-thawed embryo transfer cycles: a study protocol for a randomised controlled trial.27.302
Infertility-related stress, anxiety and ovarian stimulation: can couples be reassured about the effects of psychological factors on biological responses to assisted reproductive technology?27.302
Trust women to choose: a response to John a Robertson's 'Egg freezing and Egg banking: empowerment and alienation in assisted reproduction'.27.302
Cumulative live birth rates according to the number of oocytes retrieved after the first ovarian stimulation for in vitro fertilization/intracytoplasmic sperm injection: a multicenter multinational analysis including ∼15,000 women27.302
Multicenter evaluation of the Access AMH antimüllerian hormone assay for the prediction of antral follicle count and poor ovarian response to controlled ovarian stimulation27.302
In-vitro fertilization (IVF), embryo transfer (ET) and assisted reproduction in the State of Israel27.302
Reply: Low as well as high serum P4 levels in the early and mid-luteal phase reduce the chance of a live birth following IVF treatment with fresh embryo transfer27.302
Low as well as high serum P4 levels in the early and mid-luteal phase reduce the chance of a live birth following IVF treatment with fresh embryo transfer: where is the evidence?27.302
Abstracts for 2018 Foundation for Reproductive Medicine Translational Reproductive Biology and Clinical Reproductive Endocrinology Conference27.302
Position statement on West Nile virus: a committee opinion27.302
Preimplantation genetic testing for aneuploidy is cost-effective, shortens treatment time, and reduces the risk of failed embryo transfer and clinical miscarriage27.302
Application of seminal plasma to female genital tract prior to embryo transfer in assisted reproductive technology cycles (IVF, ICSI and frozen embryo transfer)27.302
Sharing of human leukocyte antigens in couples with unexplained infertility affects the success of in vitro fertilization and tubal embryo transfer27.302
Is it safe to perform a controlled ovarian stimulation for assisted reproduction in young breast cancer survivors?27.302
Misconduct in third-party assisted reproduction: an Ethics Committee opinion27.302
Observational retrospective study of US national utilisation patterns and live birth rates for various ovarian stimulation protocols for in vitro fertilisation27.302
THE OPTIMAL INTERVAL OF TIME FROM OPERATIVE HYSTEROSCOPY TO EMBRYO TRANSFER IN AN IVF CYCLE27.302
Disclosure of sex when incidentally revealed as part of preimplantation genetic testing (PGT): an Ethics Committee opinion27.302
Ethical obligations in fertility treatment when intimate partners withhold information from each other: an Ethics Committee opinion27.302
Use of preimplantation genetic testing for monogenic defects (PGT-M) for adult-onset conditions: an Ethics Committee opinion27.302
Gender reassignment and assisted reproduction: An ethical analysis. Bristol Centre for Reproductive Medicine Ethics Advisory Committee27.302
Shared-risk or refund programs in assisted reproduction. The Ethics Committee of the American Society for Reproductive Medicine27.302
Is tissue factor pathway inhibitor a marker of procoagulable status in healthy infertile women undergoing ovarian stimulation for assisted reproduction?27.302
The effectiveness of sublingual progesterone administration during cryopreserved embryo transfer cycles: results of a matched follow-up study**Presented in part at the 51st Annual Meeting of the American Society for Reproductive Medicine, Seattle, Wa27.302
Mid-Luteal 17-OH Progesterone Levels in 614 Women Undergoing IVF-Treatment and Fresh Embryo Transfer—Daytime Variation and Impact on Live Birth Rates27.302
Cumulative pregnancy and live birth rates in women with antiphospholipid antibodies undergoing assisted reproduction27.302
Unexplained Infertility and the Possibilities of Management with In Vitro Fertilization and Embyro Transfer27.302
Recombinant versus urinary gonadotrophin for ovarian stimulation in assisted reproductive technology cycles. A Cochrane review27.302
Controlled ovarian stimulation protocols for assisted reproduction: a network meta-analysis27.302
Large for gestational age and macrosomia in singletons born after frozen/thawed embryo transfer (FET) in assisted reproductive technology (ART)27.302
Cumulative Live Birth Rates After Cleavage-stage Versus Blastocyst-stage Embryo Transfer27.302
Study to Evaluate if the Addition of r-hLH (Luveris®) to FSH From Day 8 of Ovarian Stimulation is Able to Decrease Total FSH Dose and to Improve Cycle Outcome in Infertile Women Undergoing ART, Who Required High FSH Dose in a Previous Cycle27.302
Single Human Embryo Transfer in Assisted Reproduction Programs27.302
Recombinant FSH Investigation in the Treatment of Infertility With Assisted Reproductive Technology (ART) (RITA-1)27.302
Recombinant FSH Investigation in the Treatment of Infertility With Assisted Reproductive Technology (ART) (RITA-2)27.302
Health in Childhood Following Assisted Reproductive Technology27.302
Clinical and Live Birth Rates After Following Long Antagonist Protocol Versus Classical Antagonist Protocol27.302
GnRH Agonist at Embryo Transfer: IVF Outcomes27.302
Clinical Cohort Study on the Endocrinology and Vaginal Microbiome of the Luteal Phase in Assisted Reproduction27.302
Comparing Ovarian Stimulation for Assisted Reproduction With Two Different Forms of Pituitary Suppression27.302
Study to Examine Effect of Recombinant Luteinizing Hormone (r-Lh) and Recombinant Human Chorionic Gonadotropin (r-hCG) for Ovarian Stimulation in Assisted Reproduction Techniques (ART)27.302
Does Letrozole Improve Pregnancy Outcome in Fresh Embryo Transfer IVF/ICSI Cycle?27.302
Comparison of Blood Flow in the Arteriae Uterinae in Ovarian Stimulation Cycles27.302
Clinical and Live Birth Rates After Following Long Antagonist Protocol Versus Long Agonist Protocol27.302
Abstracts for 2017 Foundation for Reproductive Medicine Translational Reproductive Biology and Clinical Reproductive Endocrinology Conference27.302
Neonatal outcomes following different ovarian stimulation protocols in fresh single embryo transfer27.302
Safety data for the use of nasal human menopausal gonadotropins: a potential novel approach for fertility treatment27.302
A cost-effectiveness analysis of preimplantation genetic testing for aneuploidy (PGT-A) for up to three complete assisted reproductive technology cycles in women of advanced maternal age27.302
Risk of Preeclampsia in Pregnancies After Assisted Reproductive Technology and Ovarian Stimulation27.302
Comparison of the Number of Oocytes Obtained Between Chinese and Caucasian Women in IVF Treatment27.302
Efficacy of Hypnosis During Embryo Transfer Procedure on Clinical Pregnancy Rate for Patients Undergoing Assisted Reproductive Technology IVF or ICSI27.302
Evidence-based Stimulation Trial With Human rFSH in Europe and Rest of World 227.302
Evidence-based Stimulation Trial With Human rFSH in Europe and Rest of World 127.302
Letrozole in Assisted Reproductive Technology27.302
Biomarkers of Ovarian Reserve and Correlation With IVF Treatments27.302
A Dose-response Trial Using FE 999049 in Japanese Women Undergoing in Vitro Fertilisation (IVF) / Intracytoplasmic Sperm Injection (ICSI) Treatment27.302
Evaluation of Efficacy and Safety of Highly Purified Urofollitropin in Chinese Females Undergoing an Assisted Reproductive Technology (ART) Program27.302
A Phase III Study of FE 999913 in Japanese Female Patients Undergoing Fertility Treatment27.302
Electro-acupuncture and Assisted Reproductive Technology27.302
Bed Rest or no Bed Rest?27.302
Convenience and Safety of Assisted Reproductive Technology Procedures Using a Gonal-F Filled by Mass (Fbm) Liquid Formulation Applied by Pen for Ovulation Induction and In-vitro Fertilization27.302
The Effect of Selective Serotonin Reuptake Inhibitor (SSRI) Treatment on Affective Symptoms and Fertility Treatment Outcome in Women Undergoing in Vitro Fertilization (IVF)27.302
CONSORT Randomized Controlled Trial in Assisted Reproductive Technology27.302
Egg Freezing Pilot Study27.302
MENOPUR in Gonadotrophin-releasing Hormone (GnRH) Antagonist Cycles With Single Embryo Transfer27.302
Temporally Splitting Ovarian Stimulation and Embryo Transfer27.302
Study of Oral Dehydroepiandrosterone(DHEA) to Treat Previously Unexplained Infertility27.302
EmbryoGlue as an Embryo Transfer Medium27.302
Efficacy and Safety of FE 999049 in Controlled Ovarian Stimulation in Pan-Asian Women27.302
The Accuracy of Endometrial Ultrasound to Predict Implantation27.302
Uterine Flushing With Human Chorionic Gonadotrophin and Unexplained Infertility27.302
Influence of Post-thaw Embryo Culture Interval on Assisted Reproduction Success Rates27.302
DuoStim in Cases of PGT: Comparison of Embryo Quantity and Embryonic Quality Using MitoScore27.302
Urinary Versus Recombinant Gonadotropins for Ovarian Stimulation in Women Undergoing Treatment with Assisted Reproductive Technology27.302
Clinical outcomes following long GnRHa ovarian stimulation with highly purified human menopausal gonadotropin plus rFSH or rFSH in patients undergoing in vitro fertilization-embryo transfer: a multi-center randomized controlled trial.27.302
Endometrial Scratch Injury in Women With Unexplained Infertility Undergoing IUI27.302
HRT Versus MOS for Endometrial Preparation Prior to FET in PCOS Patients27.302
Time-lapse Monitoring of Early Embryo Development After Ovarian Stimulation During Infertility Treatment27.302
Effect of Local Injury on Implantation27.302
Immediate Versus Delayed FET Following a Stimulated IVF Cycle27.302
Pharmacogenetic Algorithm for Individualized Controlled Ovarian Stimulation27.302
To Investigate the Cumulative Live Birth Rates Using GnRH Antagonist or Agonist Protocol for COS in ART Treatment27.302
Newborns From Patients Treated With ART (Assisted Reproductive Technology)27.302
The Use of an Online Learning and Consent Platform in Infertility Treatment27.302
Efficacy and Safety of FE 999049 in Controlled Ovarian Stimulation in Japanese Women27.302
NATural Ovarian Stimulation27.302
Mapping the Endocrine Determinants of Ovarian Stimulation to Optimize Outcomes in Fresh Embryo Transfer Cycles27.302
Study Comparing Outcomes Between Conventional IVF and a "Freeze-all"-Strategy in Assisted Reproductive Technology27.302
A Study to Explore Correlation Between Symptoms and Signs of Polycystic Ovarian Syndrome (PCOS) and Risk of Over-response to Ovarian Stimulation27.302
Efficacy of Corifollitropin Alfa Versus Follitropin Beta in Aged IVF (In-vitro Fertilization) Patients27.302
HRT Versus MOS for Endometrial Preparation Prior to FET in Non PCOS Patients27.302
In vitro fertilization-embryo transfer (IVF-ET) in the United States: 1990 results from the IVF-ET Registry. Medical Research International. Society for Assisted Reproductive Technology (SART), The American Fertility Society27.302
A randomized trial between GIFT and ovarian stimulation for the treatment of unexplained infertility and failed artificial insemination by donor27.302
The performance of primary and secondary unexplained infertility in an in vitro fertilization-embryo transfer program27.302
In vitro fertilization-embryo transfer (IVF-ET) in the United States: 1989 results from the IVF-ET Registry. Medical Research International, Society for Assisted Reproductive Technology, The American Fertility Society27.302
Evaluation of the Hamilton-Thorn 2030 motility analyser for routine semen analysis in an infertility clinic27.302
In vitro fertilization-embryo transfer in the United States: 1988 results from the IVF-ET Registry. Medical Research International. Society for Assisted Reproductive Technology. American Fertility Society27.302
Outcome of in-vitro fertilization and embryo transfer after different regimens of ovarian stimulation27.302
Differential indications for surgical technics in reproductive medicine--microsurgery, in vitro fertilization and embryo transfer, gamete intrafallopian transfer and tubal embryo transfer27.302
Clomiphene-HMG ovarian stimulation in human in vitro fertilization and embryo transfer27.302
In vitro fertilization and other assisted reproduction. Vth World Congress on In Vitro Fertilization and Embryo Transfer. Norfolk, Virginia, April 5-10, 1987. Proceedings27.302
An analysis of the LH profile in relation to ovarian stimulation regimes and embryo transfer rates in an in vitro fertilisation programme27.302
The effect of periovarian adhesions on follicular development in patients undergoing ovarian stimulation for in vitro fertilization-embryo transfer27.302
Morphometric characteristics of endometrial biopsies after different types of ovarian stimulation for infertility treatment27.302
Gamete intra-Fallopian transfer or in-vitro fertilization after failed ovarian stimulation and intrauterine insemination in unexplained infertility?27.302
Sonographically monitored ovarian stimulation for assisted reproduction: a prospective, blind study27.302
Assisted reproductive technology in the United States and Canada: 1994 results generated from the American Society for Reproductive Medicine/Society for Assisted Reproductive Technology Registry27.302
In vitro fertilization/embryo transfer in unexplained infertility and minimal peritoneal endometriosis27.302
Fallopian Tube Sperm Perf usion Has No Advantage over Intra-uterine Insemination when Used in Combination with Ovarian Stimulation for the Treatment of Unexplained Infertility27.302
Methodology of human embryo transfer following assisted reproduction27.302
Immunity to zona pellucida in women with low response to ovarian stimulation, in unexplained infertility and after multiple IVF attempts27.302
A prospective randomized crossover comparison of zygote intrafallopian transfer and in vitro fertilization-embryo transfer in unexplained infertility27.302
Assisted reproductive technology in the United States and Canada: 1993 results generated from the American Society for Reproductive Medicine/Society for Assisted Reproductive Technology Registry27.302
The results of in vitro fertilization-embryo transfer in couples with unexplained infertility failing to conceive with superovulation and intrauterine insemination27.302
Luteinizing hormone (LH) surge in patients using buserelin spray during ovarian stimulation for assisted reproduction27.302
Reproductive medicine and assisted reproduction--present status and perspectives in the Czech Republic27.302
Serum oestradiol and progesterone concentrations during prolonged coasting in 15 women at risk of ovarian hyperstimulation syndrome following ovarian stimulation for assisted reproduction treatment27.302
Assisted reproductive technology in the United States: 1997 results generated from the American Society for Reproductive Medicine/Society for Assisted Reproductive Technology Registry27.302
A comparison of early gestational age markers in viable twin pregnancies resulting from in vitro fertilization-embryo transfer versus spontaneous conception with ovarian stimulation27.302
A rational basis for antiphospholipid antibody testing and selective immunotherapy in assisted reproduction: a rebuttal to the American Society for Reproductive Medicine Practice opinion. American Society for Reproductive Immunology Antiphospholipid27.302
Relationship between semen cultures, leukospermia, and semen analysis in men undergoing fertility evaluation27.302
The influence of infertility treatment and assisted reproduction techniques on multiple pregnancy rates27.302
Recombinant versus urinary FSH for ovarian stimulation in assisted reproduction27.302
Round spermatid nucleus injection (ROSNI)27.302
Embryo transfer: a critical step in assisted reproduction27.302
A case of forearm amputation after ovarian stimulation for in vitro fertilization-embryo transfer27.302
Use of a single bolus of GnRH agonist triptorelin to trigger ovulation after GnRH antagonist ganirelix treatment in women undergoing ovarian stimulation for assisted reproduction, with special reference to the prevention of ovarian hyperstimulation27.302
Assisted Reproductive Technology in the United States and Canada: 1995 Results Generated from the American Society for Reproductive Medicine/Society for Assisted Reproductive Technology Registry27.302
Leukaemia inhibitory factor (LIF) gene mutations in women with unexplained infertility and recurrent failure of implantation after IVF and embryo transfer27.302
Transfer of early-cleaved embryos increases implantation rate in patients undergoing ovarian stimulation and ICSI-embryo transfer27.302
A real-life prospective health economic study of elective single embryo transfer versus two-embryo transfer in first IVF/ICSI cycles27.302
The Impact of Lifestyle on Sperm Telomere Length and Telomerase Activity in Men Undergoing IVF Treatments27.302
Assisted reproductive technology in the United States: 1996 results generated from the American Society for Reproductive Medicine/Society for Assisted Reproductive Technology Registry27.302
Infertility treatment and informed consent: current practices of reproductive endocrinologists27.302
Recombinant versus urinary follicle stimulating hormone for ovarian stimulation in assisted reproduction27.302
Predictive value of the results of a first IVF cycle27.302
Impact of patients' choice for single embryo transfer of a top quality embryo versus double embryo transfer in the first IVF/ICSI cycle27.302
Follitropin-alfa for ovarian stimulation during assisted reproduction treatment: a national collaborative study27.302
Effectiveness and treatment for unexplained infertility27.302
The role of assisted hatching in in vitro fertilization: a review of the literature. A Committee opinion27.302
Ovarian tissue and oocyte cryopreservation27.302
Correct coding for laboratory procedures during assisted reproductive technology cycles27.302
Preimplantation genetic diagnosis27.302
Guidelines on number of embryos transferred27.302
Revised guidelines for human embryology and andrology laboratories27.302
Access to fertility treatment by gays, lesbians, and unmarried persons27.302
[Towards a single embryo transfer: predictive value of uterine and embryological parameters in assisted reproduction outcome]27.302
Cervical dilatation with hygroscopic rods prior to ovarian stimulation facilitates embryo transfer27.302
Revised minimum standards for practices offering assisted reproductive technologies27.302
Elective single embryo transfer in assisted reproduction27.302
Graduated Embryo Score and soluble human leukocyte antigen-G expression improve assisted reproductive technology outcomes and suggest a basis for elective single-embryo transfer27.302
Health of children born after the infertility treatment with Assisted Reproduction Technology27.302
Correct coding for laboratory procedures during assisted reproductive technology cycles27.302
Extended encounters with midwives at the first IVF cycle: a controlled trial27.302
Removal of cervical mucus prior to embryo transfer improves pregnancy rates in women undergoing assisted reproduction27.302
First IVF treatment--short-term impact on psychological well-being and the marital relationship27.302
Assisted reproductive technology practice patterns and the impact of embryo transfer guidelines in the United States27.302
The relative contribution of assisted reproductive technologies and ovulation induction to multiple births in the United States 5 years after the Society for Assisted Reproductive Technology/American Society for Reproductive Medicine recommendation27.302
Guidelines for advertising by ART programs27.302
Guidelines on the number of embryos transferred27.302
Guidelines for advertising by ART programs27.302
Revised minimum standards for practices offering assisted reproductive technologies27.302
Correct coding for laboratory procedures during assisted reproductive technology cycles27.302
Round spermatid nucleus injection (ROSNI)27.302
Blastocyst production and transfer in clinical assisted reproduction27.302
Shared-risk or refund programs in assisted reproduction27.302
Embryo splitting for infertility treatment27.302
Assisted reproduction in male cancer survivors: fertility treatment and outcome in 67 couples27.302
Clinical outcome with half-dose depot triptorelin is the same as reduced-dose daily buserelin in a long protocol of controlled ovarian stimulation for ICSI/embryo transfer: a randomized double-blind clinical trial (NCT00461916)27.302
Fertility treatment when the prognosis is very poor or futile27.302
Would legislation imposing single embryo transfer be a feasible way to reduce the rate of multiple pregnancies after IVF treatment?27.302
In vitro fertilization laboratory. Clinical features of assisted reproduction techniques. Male infertility treatment in a reproduction medicine centre27.302
Assisted reproductive technology has been detrimental to academic reproductive endocrinology and infertility27.302
Assisted reproductive technology has been detrimental to academic reproductive endocrinology and infertility: depth of the problem and possible solutions27.302
Elective single embryo transfer versus double embryo transfer in assisted reproduction27.302
Single embryo transfer in IVF treatment27.302
Recombinant gonadotrophins in reproductive medicine: gold standard for ovarian stimulation therapy in the 21st century27.302
Effect of embryo transfer number on singleton and twin implantation pregnancy outcomes after assisted reproductive technology27.302
Variability of endometrial glandular opening count in infertile patients prior to first IVF treatment27.302
Response by the leadership of the Society of Assisted Reproductive Technology (SART) to the article “Assisted Reproduction and Choices in the Biotech Age”27.302
Guidelines for reducing the risk of viral transmission during fertility treatment27.302
Genetic considerations related to intracytoplasmic sperm injection (ICSI)27.302
The role of assisted hatching in in vitro fertilization: a review of the literature. A Committee opinion27.302
Correct coding for laboratory procedures during assisted reproductive technology cycles27.302
Ovarian tissue and oocyte cryopreservation27.302
Revised guidelines for human embryology and andrology laboratories27.302
An observational study of assisted reproductive technology outcomes in new European Union member states: an overview of protocols used for ovarian stimulation27.302
Re: Paternal Body Mass Index is Associated With Decreased Blastocyst Development and Reduced Live Birth Rates Following Assisted Reproductive Technology27.302
Acupuncture intervention combined with assisted reproductive technology: its different effects at different time points during the in vitro fertilization-embryo transfer course27.302
Personality and intrapersonal and interpersonal functioning of women starting their first IVF treatment27.302
Effect of the new legislation and single-embryo transfer policy in Turkey on assisted reproduction outcomes: preliminary results27.302
Racial and ethnic disparities in assisted reproductive technology pregnancy and live birth rates within body mass index categories27.302
Committee opinion: role of tubal surgery in the era of assisted reproductive technology27.302
Practice patterns and outcomes with the use of single embryo transfer in the United States27.302
Recommendations for practices utilizing gestational carriers: an ASRM Practice Committee guideline27.302
Prediction of ovarian reserve, poor response and pregnancy outcome based on basal antral follicle count and age in patients undergoing in vitro fertilization-embryo transfer27.302
Fertility treatment when the prognosis is very poor or futile: a committee opinion27.302
Reproductive endocrinology: Infertility treatment in PCOS--is metformin in from the cold?27.302
Results after assisted reproduction at a public fertility clinic27.302
Subtle progesterone rise on the day of human chorionic gonadotropin administration is associated with lower live birth rates in women undergoing assisted reproductive technology: a retrospective study with 2,555 fresh embryo transfers27.302
Position statement on West Nile virus: a committee opinion27.302
Correct coding for laboratory procedures during assisted reproductive technology cycles27.302
Recombinant FSH versus clomiphene citrate for ovarian stimulation in couples with unexplained infertility and male subfertility undergoing intrauterine insemination: a randomized trial27.302
Guidelines on number of embryos transferred27.302
Strategies for hormonal ovarian stimulation in IVF, based on materials of the centre for assisted reproduction "varna"27.302
Effect of different embryo transfer strategies on the outcome of assisted reproduction27.302
Re: "Estimation of the contribution of non-assisted reproductive technology ovulation stimulation fertility treatments to US singleton and multiple births"27.302
Criteria for number of embryos to transfer: a committee opinion27.302
Uterine contractile activity at Embryo Transfer – as a new pharmacotherapeutic target in assisted reproduction27.302
AIUM Practice Guideline for the Performance of a Focused Reproductive Endocrinology and Infertility Scan27.302
Re: Fruit and Vegetable Intake and Their Pesticide Residues in Relation to Semen Quality among Men from a Fertility Clinic27.302
Use of reproductive technology for sex selection for nonmedical reasons27.302
[Assisted Reproductive Technology in Female Transplant Recipients: Experience of a Reproductive Medicine Unit and Literature Review]27.302
Role of baseline antral follicle count and anti-Mullerian hormone in the index stimulation cycle of IVF treatment in predicting outcome of subsequent frozen-thawed embryo transfers27.302
Corrigendum to 'Hysteroscopy prior to a first IVF treatment cycle: the need for well-performed RCT' [Reproductive BioMedicine Online 29 (2014) 142-142]27.302
Successful pregnancy following assisted reproduction and transmyometrial embryo transfer in a patient with anatomical distortion of the cervical canal27.302
Hysteroscopy prior to a first IVF treatment cycle: the need for well-performed RCT27.302
Response: Hysteroscopy prior to a first IVF treatment cycle: the need for well-performed RCT27.302
Validity for assisted hatching on pregnancy rate in assisted reproductive technology: Analysis based on results of Japan Assisted Reproductive Technology Registry System 201027.302
Is gonadotropin ovarian stimulation for unexplained infertility any longer warranted?27.302
Effectiveness of mild ovarian stimulation versus GnRH agonist protocol in women undergoing assisted reproductive technology: a meta-analysis27.302
Midluteal Progesterone: A Marker of Treatment Outcomes in Couples With Unexplained Infertility27.302
Pharmacogenetic algorithm for individualized controlled ovarian stimulation in assisted reproductive technology cycles27.302
Models for predicting live birth before a first IVF cycle27.302
Personalized ovarian stimulation for assisted reproductive technology: study design considerations to move from hype to added value for patients27.302
Comparison of pregnancy rates for poor responders using IVF with mild ovarian stimulation versus conventional IVF: a guideline27.302
Endometriosis does not affect live birth rates of patients submitted to assisted reproduction techniques: analysis of the Latin American Network Registry database from 1995 to 201127.302
Preimplantation genetic testing in assisted reproductive technology27.302
ASRM standard embryo transfer protocol template: a committee opinion27.302
Compassionate transfer: patient requests for embryo transfer for nonreproductive purposes27.302
Use of exogenous gonadotropins for ovulation induction in anovulatory women: a committee opinion27.302
Timing of frozen-thawed embryo transfer after controlled ovarian stimulation in a non-elective freeze-all policy27.302
Current Preventive Strategies for Preovulatory Progesterone Elevation During Ovarian Stimulation for In Vitro Fertilization27.302
Reporting assisted reproductive technology success rates on Australian and New Zealand fertility clinic websites27.302
The effect of fresh IVF cycle characteristics on frozen embryo transfer (FET) outcomes27.302
Evidence-based treatments for couples with unexplained infertility: a guideline27.302
Predictors of twin pregnancy after ovarian stimulation and intrauterine insemination in women with unexplained infertility27.302
Minimum standards for practices offering assisted reproductive technologies: a committee opinion27.302
Preimplantation genetic testing in assisted reproduction technology27.302
Live birth rate comparison of three controlled ovarian stimulation protocols for in vitro fertilization-embryo transfer in patients with diminished ovarian reserve after endometrioma cystectomy: a retrospective study27.302
Single and double embryo transfer provide similar live birth rates in frozen cycles27.302
Assisted Reproductive Technology and the Reproductive Endocrinology and Infertility Specialist in the U.S. Military27.302
High serum Antimullerian hormone levels are associated with lower live birth rates in women with polycystic ovarian syndrome undergoing assisted reproductive technology27.302
Re: Assisted Reproductive Technology Outcomes in Female-to-Male Transgender Patients Compared with Cisgender Patients: A New Frontier in Reproductive Medicine27.302
Preimplantation genetic testing for aneuploidy versus morphology as selection criteria for single frozen-thawed embryo transfer in good-prognosis patients: a multicenter randomized clinical trial27.302
Herbal fertility treatments used in North America from colonial times to 1900, and their potential for improving the success rate of assisted reproductive technology27.302
Elective Single Embryo Transfer in the Setting of Funded In Vitro Fertilization: Two Years' Experience in an Ontario Hospital-Based Fertility Clinic27.302
Curative effect of assisted reproduction technology by Traditional Chinese Medicine multi-channel interventional therapy on 95 cases of in vitro fertilization and embryo transfer failure27.302
Ovarian stimulation and assisted reproductive technology outcomes in women transplanted with cryopreserved ovarian tissue: a systematic review27.302
Assisted reproductive technology outcomes in female-to-male transgender patients compared with cisgender patients: a new frontier in reproductive medicine27.302
Assessment of Turkey IVF (In Vitro Fertilization) websites according to the American Society for Reproductive Medicine (ASRM)/Society for Assisted Reproductive Technology (SART) guidelines27.302
New trial of progestin-primed ovarian stimulation using dydrogesterone versus a typical GnRH antagonist regimen in assisted reproductive technology27.302
Effect of Progestin-primed Ovarian Stimulation Protocol on Outcomes of Aged Infertile Women Who Failed to Get Pregnant in the First IVF/ ICSI Cycle: A Self-controlled Study27.302
Low serum progesterone the day prior to frozen embryo transfer of euploid embryos is associated with significant reduction in live birth rates27.302
Low LH Level on the Day of GnRH Agonist Trigger Is Associated With Reduced Ongoing Pregnancy and Live Birth Rates and Increased Early Miscarriage Rates Following IVF/ICSI Treatment and Fresh Embryo Transfer27.302
Prospective randomized trial comparing efficacy of letrozole step-up protocol with letrozole plus gonadotropins for controlled ovarian stimulation and intrauterine insemination in patients with unexplained infertility27.302
Second-generation preimplantation genetic testing for aneuploidy in assisted reproduction: a SWOT analysis27.302
Luteal-phase progesterone supplementation in non-IVF treatment: a survey of physicians providing infertility treatment27.302
Oocyte exposure to supraphysiological estradiol during ovarian stimulation increased the risk of adverse perinatal outcomes after frozen-thawed embryo transfer: a retrospective cohort study27.302
A quality management approach to controlled ovarian stimulation in assisted reproductive technology: the "Fischer protocol"27.302
Influence of surgical evacuation on pregnancy outcomes of subsequent embryo transfer cycle following miscarriage in an initial IVF cycle: a retrospective cohort study27.302
Effect of embryo transfer difficulty on live birth rates studied in vitrified-warmed euploid blastocyst transfers27.302
Ovarian stimulation for preimplantation genetic testing27.302
Live birth rates and perinatal outcomes when all embryos are frozen compared with conventional fresh and frozen embryo transfer: a cohort study of 337,148 in vitro fertilisation cycles27.302
Live birth rates after different endometrial preparation methods in frozen cleavage-stage embryo transfer cycles: a randomized controlled trial27.302
Live birth rates with a freeze-only strategy versus fresh embryo transfer: secondary analysis of a randomized clinical trial27.302
Vaginal cuff dehiscence following controlled ovarian stimulation recognized during egg retrieval27.302
Defining thresholds for abnormal premature progesterone levels during ovarian stimulation for assisted reproduction technologies27.302
Abstracts presented at the 2019 Foundation for Reproductive Medicine Conference on Translational Reproductive Biology and Clinical Reproductive Endocrinology27.302
The ethics of fertility treatment for same-sex male couples: Considerations for a modern fertility clinic27.302
[Medically Assisted Reproduction in Natural Cycle: Outcome Evaluation of a Reproductive Medicine Department]27.302
Corticosteroids Prior to Embryo Transfer in Assisted Reproduction in Women with Crohn's Disease and Ulcerative Colitis - A Nationwide Cohort Study27.302
Ovarian stimulation protocols in assisted reproductive technology: an update27.302
Preimplantation genetic testing for aneuploidy: a comparison of live birth rates in patients with recurrent pregnancy loss due to embryonic aneuploidy or recurrent implantation failure27.302
A counterintuitive lesson in family planning? Patience first: taking a "gap year" after live birth from assisted reproductive technology before frozen embryo transfer is performed27.302
Prediction of live birth and cumulative live birth rates in freeze-all-IVF treatment of a general population27.302
Risk factors for inadequate response to ovarian stimulation in assisted reproduction cycles: systematic review27.302
Conservative treatment versus surgical excision of ovarian dermoid cysts: Impact on ovarian stimulation and IVF cycle success27.302
Different anti-Műllerian hormone (AMH) levels respond to distinct ovarian stimulation methods in assisted reproductive technology (ART): Clues to better ART outcomes27.302
Measuring serum estradiol and progesterone one day prior to frozen embryo transfer improves live birth rates27.302
Use of Frozen Embryo Transfer During Fertility Treatment and Risk of Childhood Cancer27.302
Use of Frozen Embryo Transfer During Fertility Treatment and Risk of Childhood Cancer-Reply27.302
Fertility Related Quality of Life, Gonadal Function and Erectile Dysfunction in Male Partners of Couples with Unexplained Infertility27.302
[Cumulative live birth rates after frozen embryo transfer and fresh embryo transfer with oocyte numbers more than 15]27.302
Transfer of embryos with positive results following preimplantation genetic testing for monogenic disorders (PGT-M): experience of two high-volume fertility clinics27.302
Isthmocele and ovarian stimulation for IVF: considerations for a reproductive medicine specialist27.302
Comparison of a novel flexible progestin primed ovarian stimulation protocol and the flexible gonadotropin-releasing hormone antagonist protocol for assisted reproductive technology27.302
Fertility treatment when the prognosis is very poor or futile: an Ethics Committee opinion27.302
Could fertility clinics offer a sizable improvement of live birth rates by maturing post-GVBD oocytes in vitro?27.302
A Chinese practice guideline of the assisted reproductive technology strategies for women with advanced age27.302
Ovarian stimulation and egg retrieval in the acutely ill patient: special considerations27.302
Endometrial thickness on the day of embryo transfer is a poor predictor of IVF treatment outcome27.302
Analysis of embryo quality with luteal phase ovarian stimulation after failed in vitro fertilization-embryo transfer with long or ultra-long protocol27.302
Preimplantation genetic testing for aneuploidy: a comparison of live birth rates in patients with recurrent pregnancy loss due to embryonic aneuploidy or recurrent implantation failure27.302
Lower prevalence of non-cavity-distorting uterine fibroids in patients with polycystic ovary syndrome than in those with unexplained infertility27.302
Impact of Female Obesity on Cumulative Live Birth Rates in the First Complete Ovarian Stimulation Cycle27.302
Live Birth Rates in Poor Responders' Group after Previous Treatment with Autologous Platelet-Rich Plasma and Low Dose Ovarian Stimulation Compared with Poor Responders Used Only Low Dose Ovarian Stimulation Before in Vitro Fertilization27.302
The Impact of Traditional Medicine-Based Lifestyle and Diet on Infertility Treatment in Women Undergoing Assisted Reproduction: A Randomized Controlled Trial27.302
No specific adverse pregnancy outcome in singleton pregnancies after assisted reproductive technology (ART) for unexplained infertility27.302
Impact of Melatonin Supplementation in Women with Unexplained Infertility Undergoing Fertility Treatment27.302
Gonadotropins versus oral ovarian stimulation agents for unexplained infertility: a systematic review and meta-analysis27.302
Embryo transfer associated with hormone replacement therapy cycles using assisted reproductive technology increases placenta accreta spectrum27.302
Transvaginal ovarian drilling followed by controlled ovarian stimulation from the next day improves ovarian response for the poor responders with polycystic ovary syndrome during IVF treatment: a pilot study27.302
Evaluation of the effect of the elective blastocyst-stage embryo transfer and freezing strategy on the abandonment of frozen embryos under the Taiwan National Assisted Reproduction Act27.302
Spontaneous Conception during In Vitro Fertilization prior to Embryo Transfer without the Opportunity for Preimplantation Genetic Testing27.302
Patient perceptions and understanding of treatment instructions for ovarian stimulation during infertility treatment27.302
Association between testosterone, semen parameters, and live birth in men with unexplained infertility in an intrauterine insemination population27.302
Progestins versus GnRH analogues for pituitary suppression during ovarian stimulation for assisted reproductive technology: a systematic review and meta-analysis27.302
Cumulative Live Birth Rates According to Maternal Body Mass Index After First Ovarian Stimulation for in vitro Fertilization: A Single Center Analysis of 14,782 Patients27.302
Endometrial volume measured on the day of embryo transfer is not associated with live birth rates in IVF: a prospective study and review of the literature27.302
A Randomized Trial Comparing the Live Birth Rate of Immediate Versus Delayed Frozen Embryo Transfer (FET) Following a Freeze-all Strategy27.302
Trends in Live Birth Rates Attributable to Assisted Reproductive Technology in British Columbia27.302
College of American Pathologists and American Society for Reproductive Medicine accreditation of assisted reproductive technology (ART) laboratories is associated with a decrease in take home baby rates of reporting ART laboratories27.302
Erratum to: Relationship between oxidative stress and clinical pregnancy in assisted reproductive technology treatment cycles27.302
Guidelines on the number of embryos transferred27.302
No effect of ovarian stimulation and oocyte yield on euploidy and live birth rates: an analysis of 12 298 trophectoderm biopsies27.302
[Elective single embryo transfer in assisted reproduction]27.302
When is the optimal timing of frozen embryo transfer after controlled ovarian stimulation?27.302
Does a hyperechogenic endometrial mass in the uterus during controlled ovarian stimulation affect assisted reproductive technology cycle outcomes?27.302
Virtual Reality Use in Assisted Reproductive Technology27.302
Intrauterine insemination performance characteristics and post-processing total motile sperm count in relation to live birth for couples with unexplained infertility in a randomised, multicentre clinical trial27.302
Changes in the levels of selected metabolites in the culture medium as a possible tool for the embryo selection in assisted reproduction27.302
[Preparation for assisted reproductive technology in the course of infertility treatment in the female soldiers]27.302
Value of sperm acrosin activity detection in selecting the method of assisted reproduction for patients with unexplained infertility27.302
Current Therapeutic Options for Controlled Ovarian Stimulation in Assisted Reproductive Technology27.302